Author: Daniel snow

A sign is posted in front of the 23andMe headquarters in Sunnyvale, California, on Feb. 1, 2024.Justin Sullivan | Getty Images23andMe on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange Commission, according to a release. The move comes after Regeneron Pharmaceuticals said earlier this month that it will acquire “substantially all” of 23andMe’s assets for $256 million. The drugmaker came out on top following a bankruptcy auction for 23andMe, a once high-flying genetic testing company that filed for Chapter 11 bankruptcy protection in March.More CNBC health coverage23andMe said it will file a Form…

Read More

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: The S & P 500 surged 2% on Tuesday after President Donald Trump said he would delay the 50% tariff on the European Union that he threatened Friday. Stocks had dropped last Friday amid concerns that investors had grown too complacent about trade tensions and that high tariffs might soon return. This recent episode served as a reminder that the risk of increased tariffs is always present. However, it’s important…

Read More